Canonical ingredient

2-Naphthaleneacetic acid, 6-methoxy-?-methyl-, (?S)-

NAPROXEN

88 linked products

Official identifiers

CAS 22204-53-1 ChEBI CHEBI:7476 InChI InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1 InChIKey CMWTZPSULFXXJA-VIFPVBQESA-N NHPID_ID 4835 SMILES COc1ccc2cc([C@H](C)C(=O)O)ccc2c1

Names and synonyms

2-Naphthaleneacetic acid, 6-methoxy-?-methyl-, (?S)- (en)
naproxen (en)
Naproxène (fr)
Acide (?S)-6-méthoxy-?-méthyl-2-naphtalèneacétique (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing: listed; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl bioaccumulative: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl inherently toxic aquatic: Yes; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets cepa categorization: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets environmental: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl meets human health: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl persistent: No; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
dsl substance category: Organics; canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)

No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

Country or region of origin
Raw-material producer
Ingredient manufacturer
Distributor
Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

APO NAPROXEN TAB 125MG

APO-NAPROXEN / ESOMEPRAZOLE

APO-NAPROXEN / ESOMEPRAZOLE

APO-NAPROXEN EC

APO-NAPROXEN EC

APO-NAPROXEN EC TABLETS

APO-NAPROXEN SR TABLETS 750MG

AVA-NAPROXEN EC

AVA-NAPROXEN EC

MYLAN-NAPROXEN EC

MYLAN-NAPROXEN EC

MYLAN-NAPROXEN EC

MYLAN-NAPROXEN/ESOMEPRAZOLE MR

MYLAN-NAPROXEN/ESOMEPRAZOLE MR

NAPROSYN 250MG TABLETS

250 · MG · TAB

NAPROSYN 375MG TABLETS

NAPROSYN 500 MG SUPPOSITORIES

500 · MG · SUP

NAPROSYN 500 MG TABLETS

NAPROSYN E 250MG TABLETS - ECT

NAPROSYN E TAB 250MG

NAPROSYN E TAB 375MG

NAPROSYN E TAB 500MG

NAPROSYN SUP 500MG

500 · MG · SUP

NAPROSYN SUS 25MG/ML

NAPROSYN-SR TAB 750MG

NAPROXEN 125 TAB 125MG

NAPROXEN CAPSULES 200 MG

NAPROXEN LIQUID GELS